Industry news

• New polymer coating for improved cancer targeting of nanomedicine

  20 May 2022 Mandy Parrett / European Pharmaceutical Review

  A new study published in the Journal of Controlled Release reports some intriguing developments in the tumour-targeting delivery of nanomedicines.

• Preparation is key: the role of scientific due diligence in successful partnerships

  20 May 2022 European Pharmaceutical Review

  Small biopharma companies often need to partner with larger firms to achieve their goals, but such agreements can fail if preparations are poor. Here, Diane Seimetz and Jörg Schneider at Biopharma Excellence discuss how due diligence smooths the path to collaboration.

• mRNA Unlocked: How Technology Convergence Is Driving the Next Wave

  19 May 2022 Sadik Kassim / FiercePharma

  The incredible success of the two mRNA vaccines against COVID-19 sparked a surge of interest and investment in this new therapeutic modality. And because mRNA is infinitely programmable, scientists are now working on deploying it towards fighting many other diseases. Our customers have already embarked on this second wave, developing mRNA drugs to treat bacterial infections, rare genetic diseases, cancer and more.

• Researchers develop battery-free, smart contact lens that delivers glaucoma drugs on demand

  18 May 2022 FiercePharma

  Researchers in China have put forward early studies of a smart contact lens for treating glaucoma. It aims to sense rising fluid pressures within the eye and automatically deliver medication as needed.

• Russia has eliminated the shortage of therapies for epilepsy and thyroid diseases

  18 May 2022 GxPnews

  Russia’s problem with the shortage of medicines for epilepsy and thyroid diseases has been solved. This was reported in the press service of the Ministry of Health of the Russian Federation.

• New antiviral class offers hope of halting rampage of treatment-resistant viruses and beyond

  18 May 2022 James Waldron / FierceBiotech

  A totally new approach to antivirals may finally provide a solution to combating viruses that have evaded traditional therapy.

• Driving Commercial Success in New Era of Biopharmaceutical Innovation

  17 May 2022 FiercePharma

  This new era in the biopharmaceutical industry promises to introduce a wave of innovative products, including therapies for conditions with high unmet medical needs. Driven by significant investments in research and development, there are more than 7,800 products in clinical development spanning a wide range of therapeutic areas—from cancer to cardiovascular medicine and diabetes to neurology.

• The head of the Ministry of Health of the Russian Federation proposed to create a Medical association of the BRICS countries

  17 May 2022 GxPnews

  Russian Health Minister Mikhail Murashko proposed to consider the possibility of creating a medical association of BRICS countries during the 12th Meeting of BRICS Ministers of Health.

• A pilot project of neonatal SMA screening has been launched in the Krasnodar Krai

  16 May 2022 GxPnews

  All newborns of the Krasnodar Krai will be tested for spinal muscular atrophy (SMA) and primary immunodeficiency disorders (PIDs). At the moment, in most regions of Russia, large-scale newborn screening includes only five hereditary diseases: phenylketonuria, adrenogenital syndrome (adrenal cortex dysfunction), congenital hypothyroidism, galactosemia and cystic fibrosis. Neonatal heel prick is performed on all 3 to 7-day-old newborns to identify these severe diseases at the pre-symptomatic stage.

• The Cabinet of Ministers lifted the ban on the export of some medical products from the country

  16 May 2022 GxPnews

  The government has amended the lists of medical devices and consumables for pharmaceutical production, for which a temporary ban and an authorization-based procedure for export outside Russia was introduced in early March.